{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T21:38:46Z","timestamp":1791754726400,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T00:00:00Z","timestamp":1671408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T00:00:00Z","timestamp":1671408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Leiomyosarcoma is a rare malignant tumor of smooth muscle origin and represents 10\u201320% of all soft tissue sarcomas. Primary colon and rectal sarcomas constitute\u2009&lt;\u20090.1% of all large bowel malignancies. In Li\u2013Fraumeni syndrome, sarcomas are the second most frequent cancer (25%). Li\u2013Fraumeni syndrome is a genetic disease with a familial predisposition to multiple malignant neoplasms. This syndrome has an autosomal dominant pattern of inheritance and high penetrance characterized by germline <jats:italic>TP53<\/jats:italic> mutations. Patients with a history of cancer who do not meet all the \u201cclassic\u201d criteria for Li\u2013Fraumeni syndrome are considered to have Li\u2013Fraumeni-like syndrome. To the best of our knowledge, this article is the first report of a patient with rectal leiomyosarcoma as the initial phenotypic manifestation of Li\u2013Fraumeni-like syndrome. The authors also present a literature review.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 67-year-old Brazilian woman underwent anterior rectosigmoidectomy and panhysterectomy secondary to rectal leiomyosarcoma. She subsequently developed carcinomatosis and died 2\u00a0years after the operation. Her family medical history consisted of a daughter who died at 32\u00a0years of age from breast cancer, a granddaughter diagnosed with adrenocortical carcinoma at 6\u00a0years of age and two siblings who died from prostate cancer. A genetic study was carried out to identify a pathogenic variant of Li\u2013Fraumeni syndrome. In the DNA extracted from the peripheral blood leukocyte, restriction fragment length polymorphism was analyzed to search for mutations in the <jats:italic>TP53<\/jats:italic> gene. The DNA sequencing identified the germline pathogenic variant p. R337H heterozygous in exon 10 of <jats:italic>TP53<\/jats:italic>. The patient was classified as having Li\u2013Fraumeni-like syndrome.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In patients with rectal leiomyosarcoma, it is advisable to investigate the family history of cancer and perform genetic studies to screen for Li\u2013Fraumeni syndrome.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-022-03671-6","type":"journal-article","created":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T01:02:40Z","timestamp":1671411760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Rectal leiomyosarcoma as the initial phenotypic manifestation of Li\u2013Fraumeni-like syndrome: a case report and review of the\u00a0literature"],"prefix":"10.1186","volume":"16","author":[{"given":"Natalia Parisi","family":"Severino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaques","family":"Waisberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Candida Barisson Villares","family":"Fragoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Guilherme Cernaglia Aureliano","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Balsamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre Cruz","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1via","family":"de Sousa Gehrke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,19]]},"reference":[{"issue":"6","key":"3671_CR1","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.anndiagpath.2012.07.005","volume":"16","author":"G Aggarwal","year":"2012","unstructured":"Aggarwal G, Sharma S, Zheng M, Reid MD, Crosby JH, Chamberlain SM, Nayak-Kapoor A, Lee JR. Primary leiomyosarcomas of the gastrointestinal tract in the post gastrointestinal stromal tumor era. Ann Diagn Pathol. 2012;16(6):532\u201340.","journal-title":"Ann Diagn Pathol"},{"key":"3671_CR2","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1001\/archsurg.1990.01410210089014","volume":"125","author":"S Meijer","year":"1990","unstructured":"Meijer S, Peretz T, Gaynor JJ, Tan C, Hajdu SI, Brennan MF. Primary colorectal sarcoma. A retrospective review and prognostic factor study of 50 consecutive patients. Arch Surg. 1990;125:1163\u20138.","journal-title":"Arch Surg"},{"issue":"1","key":"3671_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00423-006-0092-y","volume":"392","author":"A Agaimy","year":"2007","unstructured":"Agaimy A, Wunsch PH. True smooth muscle neoplasms of the gastrointestinal tract: morphological spectrum and classification in a series of 85 cases from a single institute. Langenbeck\u2019s Arch Surg. 2007;392(1):75\u201381.","journal-title":"Langenbeck\u2019s Arch Surg"},{"issue":"Suppl 3","key":"3671_CR4","first-page":"iii102","volume":"25","author":"ESMO\/European Sarcoma Network Working Group","year":"2014","unstructured":"ESMO\/European Sarcoma Network Working Group. Soft tissue and visceral sarcomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25(Suppl 3):iii102.","journal-title":"Ann Oncol"},{"key":"3671_CR5","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/cncr.26390","volume":"118","author":"S Ognjanovic","year":"2012","unstructured":"Ognjanovic S, Olivier M, Bergemann TL, Hainaut P. Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database. Cancer. 2012;118:1387\u201396.","journal-title":"Cancer"},{"key":"3671_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/CCO.0000000000000423","volume":"30","author":"A Amadou","year":"2018","unstructured":"Amadou A, Waddington Achatz MI, Hainaut P. Revisiting tumor patterns and penetrance in germline TP53 mutation carriers: temporal phases of Li-Fraumeni syndrome. Curr Opin Oncol. 2018;30:23\u20139.","journal-title":"Curr Opin Oncol"},{"key":"3671_CR7","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1200\/JCO.2014.59.5728","volume":"33","author":"G Bougeard","year":"2015","unstructured":"Bougeard G, Renaux-Petel M, Flaman JM, Charbonnier C, Fermey P, Belotti M, Gauthier-Villars M, Stoppa-Lyonnet D, Consolino E, Brugieres L, Caron O, Benusiglio PR, Bressac-de-Paillerets B, Bonadona V, Bonaiti-Pellie C, Tinat J, Baert-Desurmont S, Frebourg T. Revisiting Li-Fraumeni syndrome from TP53 mutation carriers. J Clin Oncol. 2015;33:2345\u201352.","journal-title":"J Clin Oncol"},{"issue":"1","key":"3671_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227260","volume":"15","author":"SM Volc","year":"2020","unstructured":"Volc SM, Ramos CRN, Galv\u00e3o HCR, Felicio PS, Coelho AS, Berardineli GN, Campacci N, Sabato CDS, Abrahao-Machado LF, Santana IVV, Campanella N, Lengert AVH, Vidal DO, Reis RM, Dantas CF, Coelho RC, Boldrini E, Serrano SV, Palmero EI. The Brazilian TP53 mutation (R337H) and sarcomas. PLoS ONE. 2020;15(1): e0227260.","journal-title":"PLoS ONE"},{"issue":"3","key":"3671_CR9","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1590\/1806-9282.61.03.282","volume":"61","author":"CR Giacomazzi","year":"2015","unstructured":"Giacomazzi CR, Giacomazzi J, Netto CB, Santos-Silva P, Selistre SG, Maia AL, Oliveira VZ, Camey SA, Goldim JR, Ashton-Prolla P. Pediatric cancer and Li-Fraumeni\/Li-Fraumeni-like syndromes: a review for the pediatrician. Rev Assoc Med Bras. 2015;61(3):282\u20139.","journal-title":"Rev Assoc Med Bras"},{"issue":"2","key":"3671_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10689-016-9935-z","volume":"16","author":"RC Andrade","year":"2017","unstructured":"Andrade RC, Dos Santos AC, de Aguirre Neto JC, Nevado J, Lapunzina P, Vargas FR. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes. Fam Cancer. 2017;16(2):243\u20138.","journal-title":"Fam Cancer"},{"issue":"1","key":"3671_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13058-018-1011-1","volume":"20","author":"J Penkert","year":"2018","unstructured":"Penkert J, Schmidt G, Hofmann W, Schubert S, Schieck M, Auber B, Ripperger T, Hackmann K, Sturm M, Prokisch H, Hille-Betz U, Mark D, Illig T, Schlegelberger B, Steinemann D. Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity. Breast Cancer Res. 2018;20(1):87.","journal-title":"Breast Cancer Res"},{"key":"3671_CR12","volume-title":"AJCC cancer staging manual","year":"2017","unstructured":"Amin MB, Edge SB, Greene FL, et\u00a0al. editors. AJCC cancer staging manual. 8th ed. Cham: Springer; 2017.","edition":"8"},{"issue":"2","key":"3671_CR13","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/his.12159","volume":"63","author":"H Yamamoto","year":"2013","unstructured":"Yamamoto H, Handa M, Tobo T, Setsu N, Fujita K, Oshiro Y, Mihara Y, Yoshikawa Y, Oda Y. Clinicopathological features of primary leiomyosarcoma of the gastrointestinal tract following recognition of gastrointestinal stromal tumours. Histopathology. 2013;63(2):194\u2013207.","journal-title":"Histopathology"},{"key":"3671_CR14","first-page":"280","volume":"57","author":"HS Wang","year":"1996","unstructured":"Wang HS, Chen WS, Lin TC, Lin JK, Hsu H. Leiomyosarcoma of the rectum: a series of twelve cases. Chin Med J. 1996;57:280\u20133.","journal-title":"Chin Med J"},{"key":"3671_CR15","first-page":"161","volume":"21","author":"CL Chou","year":"2010","unstructured":"Chou CL, Chang SC, Lin TC, Chen WS, Jiang JK, Wang HS, Yang SH, Li AF, Lin JK. Clinical analysis and surgical results of primary colorectal sarcoma. J Soc Colon Rectal Surg. 2010;21:161\u20138.","journal-title":"J Soc Colon Rectal Surg"},{"key":"3671_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/(SICI)1096-9098(199809)69:1<36::AID-JSO7>3.0.CO;2-L","volume":"69","author":"P Luna-P\u00e9rez","year":"1998","unstructured":"Luna-P\u00e9rez P, Rodr\u00edguez DF, Luj\u00e1n L, Alvarado I, Kelly J, Rojas ME, Labastida S, Gonz\u00e1lez JL. Colorectal sarcoma: analysis of failure patterns. J Surg Oncol. 1998;69:36\u201340.","journal-title":"J Surg Oncol"},{"key":"3671_CR17","first-page":"73","volume-title":"Diagnostic immunohistochemistry: theranostic and genomic application","author":"LA Doyle","year":"2014","unstructured":"Doyle LA, Hornick J. Immunohistology of neoplasms of soft tissue and bone. In: Dabbs DJ, editor. Diagnostic immunohistochemistry: theranostic and genomic application. 4th ed. Philadelphia: Elsevier; 2014. p. 73\u2013129.","edition":"4"},{"issue":"8","key":"3671_CR18","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1200\/JCO.2008.16.6959","volume":"27","author":"KD Gonzalez","year":"2009","unstructured":"Gonzalez KD, Noltner KA, Buzin CH, Gu D, Wen-Fong CY, Nguyen VQ, Han JH, Lowstuter K, Longmate J, Sommer SS, Weitzel JN. Beyond Li Fraumeni syndrome: clinical characteristics of families with p53 germline mutations. J Clin Oncol. 2009;27(8):1250\u20136.","journal-title":"J Clin Oncol"},{"issue":"6","key":"3671_CR19","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1158\/0008-5472.CAN-16-2179","volume":"77","author":"B Leroy","year":"2017","unstructured":"Leroy B, Ballinger ML, Baran-Marszak F, Bond GL, Braithwaite A, Concin N, Donehower LA, El-Deiry WS, Fenaux P, Gaidano G, Langer\u00f8d A, Hellstrom-Lindberg E, Iggo R, Lehmann-Che J, Mai PL, Malkin D, Moll UM, Myers JN, Nichols KE, Pospisilova S, Ashton-Prolla P, Rossi D, Savage SA, Strong LC, Tonin PN, Zeillinger R, Zenz T, Fraumeni JF Jr, Taschner PE, Hainaut P, Soussi T. Recommended guidelines for validation, quality control, and reporting of TP53 variants in clinical practice. Cancer Res. 2017;77(6):1250\u201360.","journal-title":"Cancer Res"},{"key":"3671_CR20","unstructured":"NCCN. The National Comprehensive Cancer Network Clinical Practice Guidelines\u00ae in oncology: Li-Fraumeni syndrome (version 1.2015). \u00a92015 National Comprehensive Cancer Network, Inc. 2019."},{"issue":"5","key":"3671_CR21","first-page":"1298","volume":"54","author":"JM Birch","year":"1994","unstructured":"Birch JM, Hartley AL, Tricker KJ, Prosser J, Condie A, Kelsey AM, Harris M, Jones PH, Binchy A, Crowther D, et\u00a0al. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res. 1994;54(5):1298\u2013304.","journal-title":"Cancer Res"},{"issue":"18","key":"3671_CR22","first-page":"5358","volume":"48","author":"FP Li","year":"1988","unstructured":"Li FP, Fraumeni JF Jr, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA, Miller RW. A cancer family syndrome in twenty-four kindreds. Cancer Res. 1988;48(18):5358\u201362.","journal-title":"Cancer Res"},{"key":"3671_CR23","first-page":"101","volume":"25","author":"RA Eeles","year":"1995","unstructured":"Eeles RA. Germline mutations in the TP53 gene. Cancer Surv. 1995;25:101\u201324.","journal-title":"Cancer Surv"},{"key":"3671_CR24","first-page":"6643","volume":"63","author":"M Olivier","year":"2003","unstructured":"Olivier M, Goldgar DE, Sodha N, et\u00a0al. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Res. 2003;63:6643\u201350.","journal-title":"Cancer Res"},{"issue":"26","key":"3671_CR25","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1200\/JCO.2009.22.7967","volume":"27","author":"J Tinat","year":"2009","unstructured":"Tinat J, Bougeard G, Baert-Desurmont S, Vasseur S, Martin C, Bouvignies E, Caron O, Bressac-de Paillerets B, Berthet P, Dugast C, Bona\u00efti-Pelli\u00e9 C, Stoppa-Lyonnet D, Fr\u00e9bourg T. 2009 version of the Chompret criteria for Li Fraumeni syndrome. J Clin Oncol. 2009;27(26):e108\u20139.","journal-title":"J Clin Oncol"},{"key":"3671_CR26","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jsbmb.2019.04.011","volume":"190","author":"AM Ferreira","year":"2019","unstructured":"Ferreira AM, Brondani VB, Helena VP, Charchar HLS, Zerbini MCN, Leite LAS, Hoff AO, Latronico AC, Mendonca BB, Diz MDPE, de Almeida MQ, Fragoso MCBV. Clinical spectrum of Li-Fraumeni syndrome\/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation. J Steroid Biochem Mol Biol. 2019;190:250\u20135.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"21","key":"3671_CR27","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.1002\/cncr.33143","volume":"126","author":"EM Pinto","year":"2020","unstructured":"Pinto EM, Zambetti GP. What 20 years of research has taught us about the TP53 pR337H mutation. Cancer. 2020;126(21):4678\u201386.","journal-title":"Cancer"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03671-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-022-03671-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03671-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T01:04:26Z","timestamp":1671411866000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-022-03671-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,19]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3671"],"URL":"https:\/\/doi.org\/10.1186\/s13256-022-03671-6","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,19]]},"assertion":[{"value":"13 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All information and images were accessed with the approval of the Research Ethics Committees of the ABC Medical School (Opinion No.: 3923405) and IAMSPE (Opinion No.: 3830624). This study was carried out following the guidelines of the Declaration of Helsinki, fulfilling all requirements for retrospective studies in humans.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s next of kin for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"468"}}